aod9604 igf 1 levels Peptide Therapy Weight Loss in Connecticut AOD-9604 | Next Gen Peptides
Description
5-amino-1mq offers a different profile
Report any suspected side effects to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk
Any discussion of specific peptides or potential research findings is informational only and must not be interpreted as guidance for use in or on humans or animals.
OTHER VOLUMES AND CONCENTRATIONS MAY BE USED PROVIDED THE TOTAL MAXIMUM RECOMMENDED DOSE IS NOT EXCEEDED
AOD 9604 is not FDA-approved and is sold as a research compound
